EBF3 and melanoma: In this cohort EBF3 promoter methylation in metastatic melanomas (median = 0.22) was significantly greater than promoter methylation of primary melanomas or normal melanocytes (median= 0.08 and 0.06 respectively, P-value = 0.0004, Mann Whitney U test, Figure 5C).